Arbutus Biopharma (ABUS) Change in Taxes (2013 - 2017)
Arbutus Biopharma (ABUS) posted quarterly Change in Taxes of $108000.0 for Q3 2017, little changed on a QoQ basis from $108000.0 in Q2 2017.
Arbutus Biopharma (ABUS) Change in Taxes (2013 - 2017) Analysis & Trends
Arbutus Biopharma (ABUS) has reported Change in Taxes for 3 consecutive years, with $108000.0 the latest figure, recorded in Q3 2017.
- Quarterly Change in Taxes changed N/A year-over-year to $108000.0 in Q3 2017, while the trailing twelve-month figure through Sep 2018 was $108000.0 (down 50.0% YoY) and the FY2017 annual result came in at $108000.0, changed N/A from the prior year.
- Change in Taxes steadied at $108000.0 in Q3 2017 per ABUS's latest filing, from $108000.0 in the prior quarter.
- Over the last five years, Change in Taxes for ABUS reached as high as $108000.0 in Q2 2017 and fell as low as $10000.0 in Q2 2013.
- A 3-year average of $62750.0 and a median of $66500.0 in 2015 frame the typical range for Change in Taxes.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -8,939.03 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Arbutus Biopharma | 880.36 Mn | 785.13 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2017 | 108,000.00 |
| Sep 30, 2017 | 108,000.00 |
| Jun 30, 2017 | 108,000.00 |
| Jun 30, 2017 | 108,000.00 |
| Jun 30, 2015 | 25,000.00 |
| Jun 30, 2015 | 25,000.00 |
| Jun 30, 2013 | 10,000.00 |
| Jun 30, 2013 | 10,000.00 |